Glioblastoma Moltiforme, GBM – NEW immunotherapies stop from growing in newly diagnosed patients
Background According to interim findings of a phase II trial, the combination of INO-5401, a T-cell–activating immunotherapy and INO-9012, an immune activator of a different kind with Libtayo (Cemiplimab, a…